Results 251 to 260 of about 480,865 (305)

Extending the utility of anti-EGFR therapy in metastatic colorectal cancer. [PDF]

J Gastrointest Oncol
Cann C, Vijayvergia N.
europepmc   +1 more source

Two-step PEG-based surface functionalization of gold nanoparticles enables specific SERS imaging of EGFR in an ovarian cancer cell model. [PDF]

Mater Today Bio
Stumpo A, Coelho R, López MN, Kind L, De Roo J, Jacob F, Saxer S.   +6 more
europepmc   +1 more source

AKT Inhibitor Capivasertib as a Target for Osimertinib Combination Therapy in Lung Adenocarcinoma with <i>EGFR</i> Mutation. [PDF]

Genes (Basel)
Tokunaga T, Ishihara Y, Takeda AH, Tomioka Y, Nagata A, Kato M, Suetsugu T, Mizuno K, Ueda K, Seki N.   +9 more
europepmc   +1 more source

Baseline hematuria in autosomal dominant polycystic kidney disease. [PDF]

Clin Kidney J
Serra A, Serra JH, Severin M, Russmann S.   +3 more
europepmc   +1 more source

Advances in understanding the mechanisms underlying acquired resistance to third-generation tyrosine kinase inhibitors in non-small cell lung cancer. [PDF]

Front Cell Dev Biol
A-Lai GH, Li L, Ma G, Zhao YS, Yao P, Lin YD.   +5 more
europepmc   +1 more source

Effects of probiotic supplementation on disease progression in patients with moderate to severe chronic kidney disease: a randomized controlled trial. [PDF]

Sci Rep
Saleh SE, Elnagar SSE, Fouda MA, Sayed-Ahmed N.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

EGFR and anti-EGFR nanobodies: review and update

Journal of Drug Targeting, 2020
Targeted therapy is one of the favourable methods used in cancer treatment. Several recombinant proteins and small-molecules used for this aim include monoclonal antibodies, antibody fragments and peptides. Nanobody (Nb) is a camelid antibody fragment that is very effective in targeted therapy.
Jafar Sharifi, Mohammad Reza Khirehgesh, Fatemeh Safari, Bahman Akbari   +3 more
openaire   +2 more sources